Skip to main content


Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Fig. 1 | Cell & Bioscience

Fig. 1

From: MAP4K4: an emerging therapeutic target in cancer

Fig. 1

Schematic diagram of MAP4K4 structure. Both human and mouse MAP4K4 are composed of an N-terminal kinase domain and a C-terminal citron-homology domain. Mouse MAP4K4 contains proline-rich motifs. Sites involved in regulation of kinase activity and potential phosphorylation sites are indicated

Back to article page